## **Core Concept**
The question revolves around the diagnosis of a condition characterized by osteoblastic bone metastases, a hard irregular nodule on the prostate gland, and markedly increased levels of Prostate-Specific Antigen (PSA). This combination of findings is highly suggestive of **prostate cancer** with metastatic bone involvement.

## **Why the Correct Answer is Right**
Prostate cancer often metastasizes to bones, and these metastases are typically **osteoblastic**, meaning they lead to an abnormal hardening of the bone due to excessive bone formation. This is in contrast to osteolytic lesions, which involve bone destruction. The presence of a hard, irregular nodule on the posterior surface of the prostate gland, as detected by rectal examination, is highly suggestive of a **prostatic malignancy**. Markedly increased levels of **PSA**, a protein produced by the prostate gland, further support the diagnosis of prostate cancer, as elevated PSA levels are a common finding in patients with prostate cancer, especially in those with advanced disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include other conditions that cause bone metastases or elevated PSA, such as bladder cancer, renal cell carcinoma, or benign prostatic hyperplasia. However, these conditions are less likely to present with the specific combination of osteoblastic bone metastases, a distinct prostatic nodule, and markedly elevated PSA.
- **Option B:** Similarly, without the specific text, we can infer that any option not directly related to prostate cancer with bone metastases would be incorrect based on the clinical presentation provided.
- **Option C:** Again, without specifics, we assume this would not align with the clinical picture of prostate cancer with metastatic bone disease.
- **Option D:** This option is also not provided but would presumably represent another incorrect diagnosis.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **prostate cancer metastases are typically osteoblastic**, which distinguishes them from the osteolytic metastases often seen in other cancers, such as breast or lung cancer. Additionally, **PSA levels are a critical screening tool** for prostate cancer, and significantly elevated levels, especially in the context of a suspicious rectal exam and osteoblastic bone lesions, are highly suggestive of metastatic prostate cancer.

## **Correct Answer:** D. Prostate Cancer.